Monamine oxidase: inhibitors. 1971

B F Gurney

UI MeSH Term Description Entries
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B F Gurney
January 1963, The American journal of gastroenterology,
B F Gurney
July 1960, The Journal of the American Osteopathic Association,
B F Gurney
April 1991, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
B F Gurney
January 1967, Acta physiologica Polonica,
B F Gurney
February 1971, The Biochemical journal,
B F Gurney
May 1995, Nihon rinsho. Japanese journal of clinical medicine,
B F Gurney
November 1990, Biochemical and biophysical research communications,
B F Gurney
February 1970, Rinsho byori. The Japanese journal of clinical pathology,
B F Gurney
November 1977, Lancet (London, England),
Copied contents to your clipboard!